Pancreatic Adenocarcinoma Signature Stratification for Treatment
收藏DataMed2026-07-12 收录
官方服务：
资源简介：
This is a randomized multicentre phase II trial with a large translational component. The trial will evaluate the two standard chemotherapy regimens: modified folfirinox (mFFX) and gemcitabine/nab-paclitaxel (GA), in patients with untreated metastatic pancreatic ductal adenocarcinoma. Integrated into this phase II trial are a number of laboratory components including molecular profiling, patient derived organoid establishment, and drug testing sensitivity and other biomarkers.
提供机构：
ClinicalTrials.gov
